CARBOHYDRATE METABOLISM PARAMETERS IN CASE OF ADMINISTRATION OF ZINC-CONTAINING MEDICATIONS IN COMPLEX TREATMENT OF DIABETES MELLITUS

Автор(и)

  • O.A. Olenovych
  • N.V. Pashkovska

DOI:

https://doi.org/10.24061/2413-0737.XX.1.77.2016.22

Анотація

In order to improve treatment efficacy for patients with diabetes mellitus the possibility of administration of Zinkit (Woerwag Pharma, Germany) in a complex treatment program was studied. According to the results of a complex assessment of glycemia control indices in patients with diabetes mellitus 3 weeks after the enrollment to the study it was revealed, that additional to hypoglycemic therapy administration of zinc-containing medication not only promoted reliable decrease of fasting and 2-hours postprandial blood glucose level, but also approached glycemia indices to the goal levels of a satisfactory control of
diabetes, provided significant reduction of HbA1C level by
6,8 % of its initial level.

##submission.downloads##

Номер

Розділ

ОРИГІНАЛЬНІ ДОСЛІДЖЕННЯ